Research programme: melanin-concentrating hormone receptor 1 antagonists - Argenta Discovery
Alternative Names: ADS 103274Latest Information Update: 26 Jul 2010
At a glance
- Originator Argenta Discovery
- Developer Argenta
- Class Acetamides
- Mechanism of Action MCHR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 02 Feb 2010 Argenta Discovery has been acquired by Galapagos NV
- 25 Mar 2004 The programme is available for licensing (http://www.argentadiscovery.com)
- 25 Mar 2004 Preclinical trials in Obesity in United Kingdom (unspecified route)